(1) Rajiah P, Sinha R, Cuevas C, Dubinsky TJ, Bush Jr WH, Kolokythas O. Imaging of uncommon retroperitoneal masses. Radiographics 2011;31(4):949-976.
(2) Lee KY, Oh Y, Noh HJ, Lee YJ, Yong H, Kang E, et al. Extraadrenal paragangliomas of the body: imaging features. Am J Roentgenol 2006;187(2):492-504.
(3) Kimura N, Takayanagi R, Takizawa N, Itagaki E, Katabami T, Kakoi N, et al. Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma. Endocr Relat Cancer 2014;21(3):405-414.
(4) Gourtsoyiannis NC, Ros PR, Joseph UA. Radiologic-pathologic correlations from head to toe: understanding the manifestations of disease. Journal of Nuclear Medicine 2005;46(11):1937.
(5) Van Roggen J, Hogendoorn PC. Soft tissue tumours of the retroperitoneum. Sarcoma 2000;4.
(6) Fletcher CD, Unni KK, Mertens F. Pathology and genetics of tumours of soft tissue and bone. : Iarc; 2002.
(7) Bonvalot S, Gronchi A, Le Péchoux C, Swallow CJ, Strauss D, Meeus P, et al. Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial. The Lancet Oncology 2020;21(10):1366-1377.
(8) Nishino M, Hayakawa K, Minami M, Yamamoto A, Ueda H, Takasu K. Primary retroperitoneal neoplasms: CT and MR imaging findings with anatomic and pathologic diagnostic clues. Radiographics 2003;23(1):45-57.
(9) Clark MA, Fisher C, Judson I, Thomas JM. Soft-tissue sarcomas in adults. N Engl J Med 2005;353(7):701-711.
(10) Strauss DC, Hayes AJ, Thomas JM. Retroperitoneal tumours: review of management. The Annals of The Royal College of Surgeons of England 2011;93(4):275-280.
(11) Mota, Micaela Maciel dos Santos, Bezerra ROF, Garcia MRT. Practical approach to primary retroperitoneal masses in adults. Radiologia Brasileira 2018;51(6):391-400.
(12) Strauss D, Hayes A, Thway K, Moskovic E, Fisher C, Thomas J. Surgical management of primary retroperitoneal sarcoma. Br J Surg 2010;97(5):698-706.
(13) Gunawardane PK, Grossman A. Phaeochromocytoma and paraganglioma. Hypertension: from basic research to clinical practice: Springer; 2016. p. 239-259.
(14) WHO classification of tumours of endocrine organs
. 4th ed.: IARC; 2017.
(15) Berends AM, Buitenwerf E, de Krijger RR, Veeger NJ, van der Horst-Schrivers, Anouk NA, Links TP, et al. Incidence of pheochromocytoma and sympathetic paraganglioma in the Netherlands: a nationwide study and systematic review. Eur J Intern Med 2018;51:68-73.
(16) Neumann HP, Young Jr WF, Eng C. Pheochromocytoma and paraganglioma. N Engl J Med 2019;381(6):552-565.
(17) Lam AK. Update on adrenal tumours in 2017 World Health Organization (WHO) of endocrine tumours. Endocrine pathology 2017;28(3):213-227.
(18) Pillai S, Gopalan V, Smith RA, Lam AK. Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new era. Crit Rev Oncol 2016;100:190-208.
(19) Lenders JWM, Kerstens MN, Amar L, Prejbisz A, Robledo M, Taieb D, et al. Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. J Hypertens 2020 August 01;38(8):1443-1456.
(20) Neumann HP, Young WF, Krauss T, Bayley J, Schiavi F, Opocher G, et al. 65 YEARS OF THE DOUBLE HELIX: Genetics informs precision practice in the diagnosis and management of pheochromocytoma. Endocr Relat Cancer 2018;25(8):T201-T219.
(21) Pourian M, Mostafazadeh DB, Soltani A. Does this patient have pheochromocytoma? A systematic review of clinical signs and symptoms. Journal of Diabetes & Metabolic Disorders 2015;15(1):11.
(22) Geroula A, Deutschbein T, Langton K, Masjkur JR, Pamporaki C, Peitzsch M, et al. Pheochromocytoma and paraganglioma: Clinical feature based disease probability in relation to catecholamine biochemistry and reason for disease suspicion. European Journal of Endocrinology 2019;1(aop).
(23) Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 2002;287(11):1427-1434.
(24) Han S, Suh CH, Woo S, Kim YJ, Lee JJ. Performance of (68)Ga-DOTA-Conjugated Somatostatin Receptor-Targeting Peptide PET in Detection of Pheochromocytoma and Paraganglioma: A Systematic Review and Metaanalysis. J Nucl Med 2019 March 01;60(3):369-376.
(25) Vanderveen KA, Thompson SM, Callstrom MR, Young Jr WF, Grant CS, Farley DR, et al. Biopsy of pheochromocytomas and paragangliomas: potential for disaster. Surgery 2009;146(6):1158-1166.
(26) Siddik-Sayyid SM, Dabbous AS, Shaaban JA, Daaboul DG, Baraka AS. Catastrophic cardiac hypokinesis and multiple-organ failure after surgery in a patient with an undiagnosed pheochromocytoma: emergency excision of the tumor. J Cardiothorac Vasc Anesth 2007 December 01;21(6):863-866.
(27) Lenders JW, Duh Q, Eisenhofer G, Gimenez-Roqueplo A, Grebe SK, Murad MH, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism 2014;99(6):1915-1942.
(28) Lentschener C, Baillard C, Dousset B, Gaujoux S. DOGMA IS MADE TO BE BROKEN. WHY ARE WE POSTPONING CURATIVE SURGERY TO ADMINISTER INEFFECTIVE ALPHA ADRENORECEPTOR BLOCKADE IN MOST PATIENTS UNDERGOING PHEOCHROMOCYTOMA REMOVAL? Endocrine Practice 2019;25(2):199.
(29) Groeben H, Nottebaum B, Alesina P, Traut A, Neumann H, Walz M. Perioperative α-receptor blockade in phaeochromocytoma surgery: an observational case series. BJA: British Journal of Anaesthesia 2017;118(2):182-189.
(30) Fang F, Ding L, He Q, Liu M. Preoperative Management of Pheochromocytoma and Paraganglioma. Frontiers in Endocrinology 2020;11:783.
(31) Amar L, Lussey-Lepoutre C, Lenders JW, Djadi-Prat J, Plouin P, Steichen O. MANAGEMENT OF ENDOCRINE DISEASE: Recurrence or new tumors after complete resection of pheochromocytomas and paragangliomas: a systematic review and meta-analysis. European journal of endocrinology 2016;175(4):R135-R145.
(32) Rafat C, Zinzindohoue F, Hernigou A, Hignette C, Favier J, Tenenbaum F, et al. Peritoneal implantation of pheochromocytoma following tumor capsule rupture during surgery. The Journal of Clinical Endocrinology & Metabolism 2014;99(12):E2681-E2685.